Clinical Trial

Stem Cell Derived Exome for Treatment of Diabetic Foot

Name: Stem Cell Derived Exome for Treatment of Diabetic Foot — clinical trial record (NCT06480123)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.

Trial Details

NCT Number	NCT06480123
Lead Sponsor	Second Affiliated Hospital of Guangzhou Medical University
Conditions	Diabetic Foot, Stem Cell
Enrollment	50 participants
Start Date	2024-08-01
Primary Completion	2028-12-30 (estimated)
Study Completion	2033-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-06-28